A Rapid Blood Test to Differentiate Latent Tuberculosis from Active Disease
Technical Report,30 Sep 2018,29 Sep 2019
University of California San Diego United States
Pagination or Media Count:
The purpose of the study is to develop a blood-based TB test that meets or exceeds WHO Target Product Profiles for a rapid,biomarker-based, non-sputum triage test for detecting active TB disease. To accomplish this, the activities in Year 1 included improvements to the 3-gene mRNA signature, analysis of these improvements, prototype cartridge development, recruitment and blood collection in Moldova, and development of a secure data transmission system. Progress was made toward each of these goals, though validation of the improved signature and prototype cartridge are pending. Enrollment for Aim 2 is occurring at the expected rate. In Year 1 we developed a 9-gene signature that meets WHO TPP minimum criteria. Additional work will be done in Year 2 to improve on this signature and complete the prototype cartridge for validation and field testing.
- Medicine and Medical Research